✦ LIBER ✦

Safety and efficacy of oral ITF2357 in patients with active systemic onset juvenile idiopathic arthritis

✍ Scribed by Jelena Vojinovic; Charles A. Dinarello; Antonio Furlan; Nemanja Damjanov; Carmine D’Urzo; Tiziano Oldoni

Book ID: 116399162
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 59 KB
Volume: 48
Category: Article
ISSN: 1043-4666
DOI: 10.1016/j.cyto.2009.07.391

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PS1-33 Safety and efficacy of ITF2357, a

PS1-33 Safety and efficacy of ITF2357, an orally active histone deacetylase inhibitor in the treatment of systemic onset juvenile idiopathic arthritis

✍ J. Vojinovic; N. Damjanov; A. Furlan; C. D’Urzo; G. Susic; S. Pasic; N. Iagaru; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Safety and efficacy of an oral histone d

Safety and efficacy of an oral histone deacetylase inhibitor in systemic-onset juvenile idiopathic arthritis

✍ Jelena Vojinovic; Nemanja Damjanov; Carmine D'Urzo; Antonio Furlan; Gordana Susi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 2 views

## Abstract ## Objective The current treatment options for systemic‐onset juvenile idiopathic arthritis (JIA) are methotrexate, steroids, and biologic agents. This study was undertaken to evaluate the safety of the orally active histone deacetylase inhibitor givinostat (ITF2357) and its ability to

Safety and response to influenza vaccine

Safety and response to influenza vaccine in patients with systemic-onset juvenile idiopathic arthritis receiving tocilizumab

✍ Toshihiko Shinoki,Ryoki Hara,Utako Kaneko,Takako Miyamae… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 167 KB

Efficacy and safety of tocilizumab (TCZ)

Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (sJIA): TENDER 52-week data

✍ Fabrizio De Benedetti,Hermine Brunner,Nicola Ruperto,R Cuttica… 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 105 KB

Efficacy and safety of tocilizumab in pa

Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial

✍ Shumpei Yokota; Tomoyuki Imagawa; Masaaki Mori; Takako Miyamae; Yukoh Aihara; Sh 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 225 KB

Efficacy, pharmacokinetics, and safety o

Efficacy, pharmacokinetics, and safety of adalimumab in pediatric patients with juvenile idiopathic arthritis in Japan

✍ Imagawa, Tomoyuki; Takei, Syuji; Umebayashi, Hiroaki; Yamaguchi, Kenichi; Itoh, 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 223 KB